| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jan 16, 2025 | Sell(S) | 6K | $0.58 | $3K | 69K |
| Jan 15, 2025 | Option exercise(M) | 15K | — | $0 | 75K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jan 15, 2025 | Grant(A) | 281K | — | $0 | 281K |
| Jan 15, 2025 | Option exercise(M) | 15K | — | $0 | 44K |
| Jan 15, 2025 | Grant(A) | 63K | — | $0 | 63K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-004590) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Mersana Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.